Source: FinanzNachrichten

Menarini Silicon Biosystems.: Menarini Silicon Biosystems announces the launch of its new CELLSEARCH CTC test with the DLL3 biomarker for small cell lung cancer

This new CELLSEARCH Circulating Tumor Cell (CTC) test is now available as a Research Use Only (RUO) lab service in North America and Europe. It is currently intended for basic and pharmaceutical r...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

Chairman & CEO

Giuseppe Giorgini

CEO Approval Rating

66/100

Read more